The BioBank Dresden (BBD) at the National Center for Tumor Diseases Dresden (NCT/UCC) is jointly supported by the University Hospital Carl Gustav Carus Dresden, the Carl Gustav Carus Faculty of Medicine at TU Dresden and the German Cancer Research Center (DKFZ).
Within the BBD, biomaterial from patients and healthy volunteers is processed and stored in a quality-assured and data-protection-compliant manner. The Tumor and Normal Tissue Bank (TNTB) and the Dresden Integrated Liquid Biobank (DILB) belong to the BBD. The TNTB is affiliated with the Institute of Pathology and has one of the largest fresh tissue collections in Germany with more than 67,000 samples sent in. The Dresden Integrated Liquid Biobank (DILB) is affiliated with the Institute for Clinical Chemistry and Laboratory Medicine (IKL).
The processing, controlled cooling and freezing of the samples is fully automated. The unambiguous sample allocation is carried out via complete sample tracking from the acceptance in the clinics, through processing in the laboratory, to storage in a fully automated nitrogen storage structure at temperatures as low as minus 180 degrees Celsius. In the future, more than five million samples can be stored in nitrogen tanks.
One focus of BBD is the support of research groups in the field of oncology. Biomaterials are also available for research into other diseases.
The materials and associated data are managed centrally by a professional biomaterial information and management system (CentraXX, Kairos). The BBD has a valid data protection concept and a positive ethics vote.
In addition to the provision of biomaterials, BBD offers various services such as DNA/RNA extraction, the production of tissue microarrays (TMA), immunohistological analyses, NMR analysis and other molecular analyses. In addition, BioBank Dresden advises on collection issues in the study context as well as on ethics applications.